{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T05:58:13Z","timestamp":1648533493823},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T00:00:00Z","timestamp":1356134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00105-012-2406-z","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T14:31:10Z","timestamp":1356013870000},"page":"7-11","source":"Crossref","is-referenced-by-count":0,"title":["Neues \u00fcber heredit\u00e4re, blasenbildende Hauterkrankungen"],"prefix":"10.1007","volume":"64","author":[{"given":"L.","family":"Bruckner-Tuderman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,22]]},"reference":[{"key":"2406_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-59745-413-1_1","volume":"522","author":"Alexeev","year":"2009","unstructured":"Alexeev V, Igoucheva O (2009) Retroviral delivery of ECM genes. Methods Mol Biol 522:3\u201314","journal-title":"Methods Mol Biol"},{"key":"2406_CR2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.stem.2010.09.007","volume":"7","author":"Bilousova","year":"2010","unstructured":"Bilousova G, Roop DR (2010) Altering cell fate: from thymus epithelium to skin stem cells. Cell Stem Cell 7:419\u2013420","journal-title":"Cell Stem Cell"},{"key":"2406_CR3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1440-0960.2011.00846.x","volume":"53","author":"Boyce","year":"2012","unstructured":"Boyce AE, McGrath JA, Techanukul T et al (2012) Ectodermal dysplasia-skin fragility syndrome due to a new homozygous internal deletion mutation in the PKP1 gene. Australas J Dermatol 53:61\u201365","journal-title":"Australas J Dermatol"},{"key":"2406_CR4","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1038\/jid.2012.392","volume":"132","author":"Bruckner-Tuderman","year":"2012","unstructured":"Bruckner-Tuderman L, Has C (2012) Molecular heterogeneity of blistering disorders: the paradigm of epidermolysis bullosa. J Invest Dermatol 132:E2\u2013E5","journal-title":"J Invest Dermatol"},{"key":"2406_CR5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","volume":"12","author":"Conget","year":"2010","unstructured":"Conget P, Rodriguez F, Kramer S et al (2010) Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 12:429\u2013431","journal-title":"Cytotherapy"},{"key":"2406_CR6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-genom-090711-163739","volume":"13","author":"Desnick","year":"2012","unstructured":"Desnick RJ, Schuchman EH (2012) Enzyme replacement therapy for lysosomal diseases: lessons from 20\u00a0years of experience and remaining challenges. Annu Rev Genomics Hum Genet 13:307\u2013333","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2406_CR7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2008.02.004","volume":"58","author":"Fine","year":"2008","unstructured":"Fine J-D, Eady RAJ, Bauer EA et al (2008) The classification of inherited epidermolysis bullosa (EB): report of the third international consensus meeting on diagnosis and classification of EB. J Am Acad Dermatol 58:931\u2013950","journal-title":"J Am Acad Dermatol"},{"key":"2406_CR8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/humu.21576","volume":"32","author":"Has","year":"2011","unstructured":"Has C, Castiglia D, Rio M del et al (2011) Kindler Syndrome: extension of mutational spectrum and natural history. Hum Mutat 32:1204\u201312","journal-title":"Hum Mutat"},{"key":"2406_CR9","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1056\/NEJMoa1110813","volume":"366","author":"Has","year":"2012","unstructured":"Has C, Spart\u00e0 G, Kiritsi D et al (2012) Integrin a3 mutations with kidney, lung and skin disease. N Engl J Med 366:1508\u20131514","journal-title":"N Engl J Med"},{"key":"2406_CR10","doi-asserted-by":"crossref","unstructured":"Has C, Bruckner-Tuderman L, Uitto J (2013) Epidermolysis bullosa. In: Rimoin D, Pyeritz R, Korf B (Hrsg) Emery and Rimoin\u2019s principles and practice of medical genetics, 6. Aufl. Elsevier Ltd, Amsterdam","DOI":"10.1016\/B978-0-12-383834-6.00156-7"},{"key":"2406_CR11","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1073\/pnas.1100332108","volume":"108","author":"Itoh","year":"2011","unstructured":"Itoh M, Kiuru M, Cairo MS, Christiano AM (2011) Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci U S A 108:8797\u20138802","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2406_CR12","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","volume":"17","author":"Kern","year":"2009","unstructured":"Kern, JS Loeckermann S, Fritsch A et al (2009) Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. Mol Ther 17:1605\u20131615","journal-title":"Mol Ther"},{"key":"2406_CR13","unstructured":"K\u00fcttner V, Mack C, Rigbolt KTG et al (o J) Global remodeling of cellular microenvironment due to loss of collagen VII (zur Publikation eingereicht)"},{"key":"2406_CR14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/jid.2011.379","volume":"132","author":"Liu","year":"2012","unstructured":"Liu L, Dopping-Hepenstal PJ, Lovell PA et al (2012) Autosomal recessive epidermolysis bullosa simplex due to loss of BPAG1-e expression. J Invest Dermatol 132:742\u2013744","journal-title":"J Invest Dermatol"},{"key":"2406_CR15","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","volume":"12","author":"Mavilio","year":"2006","unstructured":"Mavilio F, Pellegrini G, Ferrari S et al (2006) Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12:1397\u20131402","journal-title":"Nat Med"},{"key":"2406_CR16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.det.2009.10.015","volume":"28","author":"McGrath","year":"2010","unstructured":"McGrath JA, Bolling MC, Jonkman MF (2010) Lethal acantholytic epidermolysis bullosa. Dermatol Clin 28:131\u2013135","journal-title":"Dermatol Clin"},{"key":"2406_CR17","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-11-2996","volume":"72","author":"Ng","year":"2012","unstructured":"Ng YZ, Pourreyron C, Salas-Alanis JC et al (2012) Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Cancer Res 72:3522\u20133534","journal-title":"Cancer Res"},{"key":"2406_CR18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2133.2011.10640.x","volume":"166","author":"Petrof","year":"2012","unstructured":"Petrof G, Mellerio JE, McGrath JA (2012) Desmosomal genodermatoses. Br J Dermatol 166:36\u201345","journal-title":"Br J Dermatol"},{"key":"2406_CR19","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/hmg\/ddr064","volume":"20","author":"Pigors","year":"2011","unstructured":"Pigors M, Kiritsi D, Krumpelmann S et al (2011) Lack of plakoglobin leads to lethal congenital epidermolysis bullosa: a novel clinico-genetic entity. Hum Mol Genet 20:1811\u20131819","journal-title":"Hum Mol Genet"},{"key":"2406_CR20","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/jid.2012.166","volume":"132","author":"Pigors","year":"2012","unstructured":"Pigors M, Kiritsi D, Cobzaru C et al (2012) TGM5 mutations impact epidermal differentiation in acral peeling skin syndrome. J Invest Dermatol 132:2422\u20132429","journal-title":"J Invest Dermatol"},{"key":"2406_CR21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/mt.2008.234","volume":"17","author":"Remington","year":"2009","unstructured":"Remington J, Wang X, Hou Y et al (2009) Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther 17:26\u201333","journal-title":"Mol Ther"},{"key":"2406_CR22","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1039\/c003962d","volume":"6","author":"Sprenger","year":"2010","unstructured":"Sprenger A, K\u00fcttner V, Biniossek M et al (2010) Comparative quantitation of proteome alterations induced by aging or immortalization in primary human fibroblasts and keratinocytes for clinical applications. Mol Biosyst 6:1579\u20131582","journal-title":"Mol Biosyst"},{"key":"2406_CR23","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/jid.2010.346","volume":"131","author":"Tolar","year":"2011","unstructured":"Tolar J, Xia L, Riddle MJ et al (2011) Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 131:848\u2013856","journal-title":"J Invest Dermatol"},{"key":"2406_CR24","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/jid.2011.389","volume":"132","author":"Uitto","year":"2012","unstructured":"Uitto J, Christiano AM, McLean WH, McGrath JA (2012) Novel molecular therapies for heritable skin disorders. J Invest Dermatol 132:820\u2013828","journal-title":"J Invest Dermatol"},{"key":"2406_CR25","first-page":"803","volume":"10","author":"Uitto","year":"2012","unstructured":"Uitto J, Has C, Bruckner-Tuderman L (2012) Zellbasierte Therapien bei Epidermolysis bullosa \u2013 vom Labor zum Patienten. J Dtsch Dermatol Ges 10:803\u2013807","journal-title":"J Dtsch Dermatol Ges"},{"key":"2406_CR26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","volume":"363","author":"Wagner","year":"2010","unstructured":"Wagner JE, Ishida-Yamamoto A, McGrath JA et al (2010) Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 363:629\u2013639","journal-title":"N Engl J Med"},{"key":"2406_CR27","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","volume":"128","author":"Wong","year":"2008","unstructured":"Wong T, Gammon L, Liu L et al (2008) Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128:2179\u20132189","journal-title":"J Invest Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-012-2406-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-012-2406-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-012-2406-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:37:58Z","timestamp":1558582678000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-012-2406-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,22]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2406"],"URL":"https:\/\/doi.org\/10.1007\/s00105-012-2406-z","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,22]]}}}